The treatment of metastatic breast cancer with 5-fluorouracil and leucovorin
Allegra, C.J.; Egan, G.F.; Drake, J.C.; Steinberg, S.M.; Swain, S.M.
Advances in Experimental Medicine and Biology 244: 107-112
1988
ISSN/ISBN: 0065-2598 PMID: 3266821 Document Number: 305921
Document emailed within 1 workday
Related Documents
Kalofonos, H.P.; Papakostas, P.; Makatsoris, T.; Papamichael, D.; Vourli, G.; Xanthakis, I.; Aravantinos, G.; Papadimitriou, C.; Pentheroudakis, G.; Varthalitis, I.; Samelis, G.; Syrigos, K.N.; Xiros, N.; Stavropoulos, M.; Kosmidis, P.; Christodoulou, C.; Linardou, H.; Skondra, M.; Pectasides, D.; Economopoulos, T.; Fountzilas, G. 2010: Irinotecan/fluorouracil/leucovorin or the same regimen followed by oxaliplatin/fluorouracil/leucovorin in metastatic colorectal cancer Anticancer Research 30(10): 4325-4333Ohtani, H.; Arimoto, Y.; Nishio, K.; Kanamiya, Y.; Oba, H.; Adachi, K.; Shintani, M.; Nakamura, R.; Yui, S. 2008: Efficacy and toxicity of fluorouracil, leucovorin plus oxaliplatin (FOLFOX4 and modified FOLFOX6) followed by fluorouracil, leucovorin plus irinotecan(FOLFIRI)for advanced or metastatic colorectal cancer--case studies Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(10): 1769-1774
Nicholson, B.; Paul, D.; Shyr, Y.; Garrett, M.; Hande, K.R.; Johnson, D.H. 1997: Paclitaxel/5-fluorouracil/leucovorin in metastatic breast cancer: a Vanderbilt Cancer Center phase Ii trial Seminars in Oncology 24(4 Suppl 11: S11
Yamaguchi, Y.; Minami, K.; Kawabuchi, Y.; Emi, M. 2006: A phase I trial of CPT-11 in combination with 5-fluorouracil plus leucovorin chemotherapy for patients with metastatic colorectal cancer Hepato-Gastroenterology 53(68): 201-205
Klaassen, U.; Seeber, S. 1997: Metastatic breast cancer: treatment with fluorouracil-based combinations Oncology 11(9 Suppl 10: 69-73
Holmes, F.A.; Yap, H.Y.; Esparza, L.; Buzdar, A.U.; Hortobagyi, G.N.; Blumenschein, G.R. 1984: Mitoxantrone, cyclophosphamide, and 5-fluorouracil in the treatment of hormonally unresponsive metastatic breast cancer Seminars in Oncology 11(3 Suppl 1: 28-31
Okabo, S.; Arai, T.; Maruyama, S.; Lee, M.; Murase, N.; Tsubaki, M.; Endo, M.; Wada, Y.; Shimoju, K.; Sakurazawa, K.; Sugihara, K.; Maruyama, M.; Yabata, E.; Kawasaki, T.; Sasaki, T. 1997: A randomized comparative study of surgical adjuvant chemotherapy using 5-fluorouracil and dl-leucovorin with CDDP 5-FU and dl-leucovorin for colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 24(7): 849-854
Klaassen, U.; Harstrick, A.; Wilke, H.; Seeber, S. 1996: Preclinical and clinical study results of the combination of paclitaxel and 5-fluorouracil/folinic acid in the treatment of metastatic breast cancer Seminars in Oncology 23(1 Suppl 1: 44-47
Zhang, H.-G.; Cai, R.-G.; Chen, S.-S.; Wu, F.; Chu, D.-T. 2007: 10-hydroxy-camptothecin plus fluorouracil/leucovorin for the treatment of patients with advanced colorectal cancer Zhonghua Yi Xue Za Zhi 87(21): 1462-1464
Sasaki, T.; Ota, K.; Taguchi, T.; Ogawa, N.; Kurihara, M.; Akazawa, S.; Ogawa, M.; Tominaga, T.; Konishi, T.; Kumai, K. 1995: A randomized early phase Ii study of l-leucovorin and 5-fluorouracil in gastric cancer. l-Leucovorin and 5-FU Study Group Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(4): 521-529
Paul, D.M.; Garrett, A.M.; Meshad, M.; DeVore, R.D.; Porter, L.L.; Johnson, D.H. 1996: Paclitaxel and 5-fluorouracil in metastatic breast cancer: the US experience Seminars in Oncology 23(1 Suppl 1: 48-52
Zhao, L.; Li, X.-y.; Bai, C.-m.; Chen, S.-c. 2008: Post-operative adjuvant treatment with oxaliplatin, fluorouracil, and leucovorin for local advanced gastric cancer Zhonghua Yi Xue Za Zhi 88(18): 1264-1266
Grem, J.L.; McAtee, N.; Steinberg, S.M.; Hamilton, J.M.; Murphy, R.F.; Drake, J.; Chisena, T.; Balis, F.; Cysyk, R.; Arbuck, S.G. 1993: A phase I study of continuous infusion 5-fluorouracil plus calcium leucovorin in combination with N-(phosphonacetyl)-L-aspartate in metastatic gastrointestinal adenocarcinoma Cancer Research 53(20): 4828-4836
Huang, W.Tsung.; Chang, K.Chao.; Shan, Y.Shen.; Tsao, C.Jung.; Lee, J.Chang. 2005: Successful initial treatment with weekly 24-hour infusion of 5-fluorouracil and leucovorin in a rectal cancer patient with acute disseminated intravascular coagulation Hepato-Gastroenterology 52(65): 1436-1439
Mitsugi, K.; Yasutake, T.; Etoh, T.; Ishimaru, T.; Ueda, A.; Nakano, S.; Niho, Y. 1993: Successful treatment of recurrent multiple lung metastasis from colon cancer with combination chemotherapy using methotrexate, 5-fluorouracil, and high-dose leucovorin: a case report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(15): 2387-2390
Klotz, H.P.; Weder, W.; Largiadèr, F. 1993: Local and systemic toxicity of intra-hepato-arterial chemotherapy for treatment of unresectable liver metastases of colorectal cancer with 5-Fluorouracil and high dose Leucovorin Helvetica Chirurgica Acta 60(1-2): 283-286
Yuasa, C.; Okabe, H.; Toko, T.; Takeda, S.; Unemi, N. 1995: Augmentation of chemotherapeutic efficaciousness of UFT by oral l-leucovorin--l-leucovorin factors enhancing cytotoxic activity of 5-fluorouracil Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(13): 1927-1932
Slee, P.H.T.J.; Rodenburg, C.J.; Nortier, J.W.R.; van Bochove, A. 2004: A phase i dose-escalating study of docetaxel plus folinic acid and 5-fluorouracil in anthracycline-pretreated patients with metastatic breast cancer Netherlands Journal of Medicine 62(9): 314-319
Iba, T.; Kidokoro, A.; Fukunaga, M.; Sugiyama, K.; Fukunaga, T.; Aihara, N. 2003: Effect and mechanism of orally administered leucovorin/5-fluorouracil on colon cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 30(13): 2077-2081
Terashima, M.; Ikeda, K.; Kawamura, H.; Maesawa, C.; Takiyama, I.; Yoshinari, H.; Koeda, K.; Sato, N.; Ishida, K.; Saito, K. 1992: Experimental study of biochemical modulation of 5-fluorouracil with l-leucovorin against human esophageal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(12): 1999-2004